MDAI
Spectral AI, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.57
+0.64%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 15.2M | 19.6M | 29.6M | 18.1M | 25.4M |
| Cost of Revenue | 8.9M | 10.7M | 16.3M | 10.2M | 14.5M |
| Gross Profit | 6.3M | 8.9M | 13.3M | 7.9M | 10.8M |
| Operating Expenses | |||||
| R&D Expense | 5.8M | 19.6M | 29.6M | — | — |
| SG&A Expense | 17.0M | 17.5M | 19.9M | 20.9M | 13.5M |
| General & Admin Expense | 16.3M | 17.5M | 19.9M | 20.9M | 13.5M |
| Selling & Marketing Expense | 653.0K | — | — | — | — |
| Other Expenses | (4.4M) | (19.6M) | (29.6M) | — | — |
| Total Operating Expenses | 18.4M | 17.5M | 19.9M | 20.9M | 13.5M |
| Cost and Expenses | 27.3M | 28.3M | 36.2M | 31.0M | 28.0M |
| Operating Income (EBIT) | (12.1M) | (8.6M) | (6.6M) | (13.0M) | (2.6M) |
| Non-Operating | |||||
| Interest Income | (547.0K) | (886.0K) | 14.0K | 172.0K | 21.0K |
| Interest Expense | 1.5M | 1.5M | 3.0M | — | — |
| Net Interest Income | (2.0M) | (2.4M) | (3.0M) | 172.0K | 21.0K |
| Other Non-Op Income/Expense | 1.7M | 1.0M | (8.5M) | (7.9M) | (159.0K) |
| Non-Operating Income (excl Interest) | (3.2M) | (2.5M) | 5.5M | 7.9M | 159.0K |
| EBT (Pre-Tax Income) | (10.4M) | (7.6M) | (15.0M) | (20.8M) | (2.8M) |
| Income Tax Expense | 141.0K | 11.0K | 271.0K | 11.0K | 106.0K |
| Bottom Line | |||||
| Net Income | (10.5M) | (7.6M) | (15.3M) | (20.9M) | (2.9M) |
| Earnings from Cont. Ops | (10.5M) | (7.6M) | (15.3M) | (20.9M) | (2.9M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (10.5M) | (7.6M) | (15.3M) | (20.9M) | (2.9M) |
| Per Share | |||||
| Basic EPS | ($0.35) | ($0.29) | ($0.85) | ($1.48) | ($0.16) |
| Diluted EPS | ($0.35) | ($0.29) | ($0.85) | ($1.48) | ($0.16) |
| Revenue Per Share | $0.47 | $0.74 | $1.65 | $1.28 | $1.42 |
| Shares | |||||
| Basic Shares Outstanding | 32.1M | 26.5M | 17.9M | 14.1M | 17.9M |
| Diluted Shares Outstanding | 32.1M | 26.5M | 17.9M | 14.1M | 17.9M |
| Profitability Metrics | |||||
| EBITDA | (8.5M) | (5.4M) | (11.5M) | (20.1M) | (2.2M) |
| D&A | 409.0K | 635.0K | 588.0K | 722.0K | 568.0K |
| EBIT | (8.9M) | (6.1M) | (12.1M) | (20.8M) | (2.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026